Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation

• Main Authors: Jeon, Jessie S. (Contributor), Bersini, Simone (Author), Gilardi, Mara (Author), Dubini, Gabriele (Author), Charest, Joseph L. (Author), Moretti, Matteo (Author), Kamm, Roger Dale (Contributor)
• Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor)
• Format: Article
• Language: English
• Published: National Academy of Sciences (U.S.), 2015-08-05T16:14:35Z.
• Subjects: Article
• Online Access: Get fulltext

A key aspect of cancer metastases is the tendency for specific cancer cells to home to defined subsets of secondary organs. Despite these known tendencies, the underlying mechanisms remain poorly understood. Here we develop a microfluidic 3D in vitro model to analyze organ-specific human breast cancer cell extravasation into bone- and muscle-mimicking microenvironments through a microvascular network concentrically wrapped with mural cells. Extravasation rates and microvasculature permeabilities were significantly different in the bone-mimicking microenvironment compared with unconditioned or myoblast containing matrices. Blocking breast cancer cell A[subscript 3] adenosine receptors resulted in higher extravasation rates of cancer cells into the myoblast-containing matrices compared with untreated cells, suggesting a role for adenosine in reducing extravasation. These results demonstrate the efficacy of our model as a drug screening platform and a promising tool to investigate specific molecular pathways involved in cancer biology, with potential applications to personalized medicine.
National Cancer Institute (U.S.) (Grant R33 CA174550-01)
National Cancer Institute (U.S.) (Grant R21 CA140096)
Italian Ministry of Health
Charles Stark Draper Laboratory (Fellowship)